Ingevity Corporation ( NGVT) - Stock Earnings
NGVT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
NGVT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -84.6 million USD | 255.1 million USD |
| 2026Q1 | 59.8 million USD | 258.0 million USD |
| 2026Q2 | 35.3 million USD | 314.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NGVT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -5.4 million USD | 1.7 billion USD |
| 2024 | -430.3 million USD | 1.4 billion USD |
| 2025 | -167.1 million USD | 1.2 billion USD |
| 2026 Est. | — | — |
NGVT
Price: $69.84
Earnings Per Share: 0.71 USD
P/E Ratio: 103.39
Exchange: NYQ
Sector: Basic Materials
Industry: Specialty Chemicals
Country: United States
Volume: 96900
Ebitda: 42.2 millionMarket Capitalization: 2.5 billion